DIVA: Final event of the project – January 21, 2021

DIVA: Final event of the project – January 21, 2021

DIVA (Innovative Devices for the prevention of recurrent VAginitis) is a project focused on the development of an innovative treatment for vaginitis in order to reduce the use of antibiotic therapy.

In this project, CVBF is a partner responsible for the clinical trial conduct including medical writing, clinical study planning and management, regulatory and ethical activities, pharmacovigilance, data management, monitoring and auditing.

The project has come to its conclusion and the final event has been held on 21 January 2021 where the results of the project have been illustrated.

2021-01-27T15:16:51+00:00 27/01/2021|Categories: News|